Cerebral microbleeds, atrial fibrillation and stroke prevention
10.3760/cma.j.issn.1673-4165.2018.02.007
- VernacularTitle:脑微出血与心房颤动及卒中预防
- Author:
Lin YANG
1
;
Xiaona XING
;
Xiaohong CHEN
Author Information
1. 116044,大连医科大学
- Keywords:
Cerebral Hemorrhage;
Stroke;
Brain Ischemia;
Atrial Fibrillation;
Anticoagulants;
Platelet Aggregation Inhibitors;
Fibrinolytic Agents;
Thrombolytic Therapy;
Magnetic Resonance Imaging;
Risk Factors
- From:
International Journal of Cerebrovascular Diseases
2018;26(2):139-144
- CountryChina
- Language:Chinese
-
Abstract:
Cerebral microbleeds (CMBs) are a imaging manifestation of small vessel disease, and have a marked impact on the recurrence and on hemorrhagic transformation of ischemic stroke. Atrial fibrillation (AF) is a common arrhythmia,w hich significantly increases the risk of stroke,and the incidence of CMB in AF patients is also significantly higher than that in non-AF patients.Antithrombotic therapy is the cornerstone of stroke prevention,but it also increases the risk of bleeding.The benefit of stroke prevention and the bleeding risk should be assessed in AF patients w ith CMBs.
